InsiderTrades

Form 4/A for AORT ARTIVION, INC.

Accepted 2024-03-14 00:00:00 ET · period of report 2024-02-23 · accession 0000784199-24-000150 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MA 2024-03-14 2024-02-23 AORT Holloway Jean F SVP, GC A - Grant $0.00 +18.2K 168.4K +12% $0
MA 2024-03-14 2024-02-26 AORT Holloway Jean F SVP, GC S - Sale $20.27 -2,838 155.6K -2% -$57.5K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-23 A A 5,386 $0.00 156,854 D — — (F1) Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.
2 Common Common Stock 2024-02-26 S D 1,543 $20.27 166,852 D — — (F5) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,566 shares were sold, when in fact, 1,543 shares were sold. (F3) As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
3 Common Common Stock 2024-02-23 A A 12,836 $0.00 168,395 D — — (F4) Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date. (F3) As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
4 Common Common Stock 2024-02-26 S D 1,295 $20.27 155,559 D — — (F2) These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,314 shares were sold, when in fact, 1,295 shares were sold. (F3) As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.